A comparative study of Duloxetine versus Escitalopram in the treatment of depression
Zhou Xiang
Abstract
Zhou Xiang
Abstract
Objective:To observe the efficacy and safety of Duloxetine and Escitalopram in the treatment of depression.Methods:Sixty-six patients with depression were randomly divided into Duloxetine group(n=33) and Escitalopram group(n=33).The patients were treated with Duloxetine(40~60mg/d)or Escitalopram(10~15mg/d) for 6 weeks.The efficacy was assessed with Hamilton depression rating scale(HAMD17) and the side effects were assessed with treatment emergent symptoms scale(TESS).Results: After the first week of treatment,the response rate was 36.36% in Duloxetine group and 33.33% in Escitalopram group without significant difference(P0.05).After the 6-weeks treatment,the response rates in Duloxetine group and Escitalopram group were 93.93% and 90.90% respectively,without significant difference(P0.05).There were no significant difference in side effect between these two groups.Conclusions: Duloxetine and Escitalopram are both effective and safe in the treatment of depression.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To observe the efficacy and safety of Duloxetine and Escitalopram in the treatment of depression.Methods:Sixty-six patients with depression were randomly divided into Duloxetine group(n=33) and Escitalopram group(n=33).The patients were treated with Duloxetine(40~60mg/d)or Escitalopram(10~15mg/d) for 6 weeks.The efficacy was assessed with Hamilton depression rating scale(HAMD17) and the side effects were assessed with treatment emergent symptoms scale(TESS).Results: After the first week of treatment,the response rate was 36.36% in Duloxetine group and 33.33% in Escitalopram group without significant difference(P0.05).After the 6-weeks treatment,the response rates in Duloxetine group and Escitalopram group were 93.93% and 90.90% respectively,without significant difference(P0.05).There were no significant difference in side effect between these two groups.Conclusions: Duloxetine and Escitalopram are both effective and safe in the treatment of depression.
Key concepts: Escitalopram, Duloxetine, Depression (economics), Duloxetine Hydrochloride, Significant difference, Internal medicine, Psychology, Medicine